Literature DB >> 9408818

Prolongation of clozapine-induced granulocytopenia associated with olanzapine.

S W Flynn, S Altman, G W MacEwan, L L Black, L L Greenidge, W G Honer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9408818     DOI： 10.1097/00004714-199712000-00014

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

1.  Olanzapine and pancytopenia with severe folate deficiency.

Authors:  F Maurier; N Petitpain; J-F Guichard; L Javot; P Tréchot
Journal:  Eur J Clin Pharmacol       Date:  2010-02-06       Impact factor: 2.953

2.  Olanzapine-associated leukopenia and thrombocytopenia managed with lithium in a patient who developed leukopenia with clozapine in the past: a case report.

Authors:  Sandeep Grover; Aditya Hegde; Munish Agarwal; Manupdesh Singh Sachdeva
Journal:  Prim Care Companion CNS Disord       Date:  2012

Review 3.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.

Authors:  Kristin N Maher; Marcus Tan; Julia W Tossell; Brian Weisinger; Peter Gochman; Rachel Miller; Deanna Greenstein; Gerald P Overman; Judith L Rapoport; Nitin Gogtay
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03       Impact factor: 2.576
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.